Toll-free: (844) 812-0776  Tel: (754) 307-9121 info@mnahealthcare.com

FDA issues black box warning for breast implants

The Food and Drug Administration placed a “black box” warning on breast implants to advise patients of health risks and side effects, according to the New York Times. Federal regulators ordered manufacturers to only sell implants to providers who agree to communicate all the risks to patients prior to surgery. The warning, along with a new checklist for patients and providers to review before surgery, states that breast implants have been linked to several serious health conditions, including a cancer of the immune system and several autoimmune diseases.


Related Posts

E-cigs linked to weaker bones

E-cigs linked to weaker bones

Use of e-cigarettes -- also known as "vaping" -- is linked to increased risk of hip, spine and wrist fractures, according to US News & World Report. Researchers at the University of Pittsburgh examined data from more than 5,500 health survey participants and found...

read more
Sodium consumption outpaces dietary recommendations

Sodium consumption outpaces dietary recommendations

If you don't watch your salt intake, it might be time to start. According to the Washington Post, American adults consume an average of 3,400 mg of salt per day -- almost 150 percent of the federal government's recommended daily maximum of 2,300 mg per day for people...

read more
Pfizer recalls anti-smoking drug Chantix

Pfizer recalls anti-smoking drug Chantix

The pharmaceutical giant Pfizer has recalled its anti-smoking drug Chantix over concerns that long-term use may elevate cancer risk, according to Healthline. According to USA Today, Pfizer initiated the voluntary recall due to concerns about high levels of...

read more
Minimum age for prediabetes screening drops

Minimum age for prediabetes screening drops

The United States Preventative Services Task Force (USPSTF) has updated its recommendations for when physicians should start to screen patients for diabetes and prediabetes. According to a statement published in the Journal of the American Medical Association, USPSTF...

read more
New Alzheimer’s drug adjustments

New Alzheimer’s drug adjustments

Biogen has updated its prescribing guidelines for its controversial Alzheimer's drug. The updated guidelines for the drug Aduhelm say the drug should be prescribed to patients with milder mental impairment and not those with advanced Alzheimer's disease. The drug was...

read more

Why MNA?


Licensing


FAQ’S


Rewards


Referrals

Why MNA?


Licensing


FAQ’S


Rewards


Referrals

Why MNA?


Licensing


FAQ’S


Rewards


Referrals

Why MNA?


Licensing


FAQ’S


Rewards


Referrals